The phrase "a terminal dose" is correct and usable in written English.
It can be used in medical or pharmaceutical contexts to refer to a dose of medication that is intended to be the final or last dose given to a patient, often in end-of-life care situations.
Example: "The doctor prescribed a terminal dose of pain relief medication to ensure the patient's comfort in their final days."
Alternatives: "final dose" or "last dose".
Compare Nokia's classic 3210 with the latest iPhone and you'd have to be metabolizing a terminal dose of nostalgia to claim the former was the better device.
But he's trying to go straight -- until a careless supervisor's order causes Max to be blasted with a terminal dose of radiation.
Rats were deeply anesthetised with a terminal dose of pentobarbital sodium and perfused transcardially with 0.1 M phosphate-buffered saline (PBS, pH 7.4), followed by 4% paraformaldehyde in PB.
Animals received a terminal dose of 60 mg/kg sodium pentobarbitone i.p. (Apoteksbolaget, Sweden) and were trans-cardially perfused with 50 ml saline (0.9% w/v), followed by 200 ml ice-cold paraformaldehyde (4% w/v in 0.1 M phosphate buffered saline).
At the peak of her addiction, the "elfin" poet, five feet one inch and a hundred pounds, was dosing herself around the clock with nearly two hundred milligrams of morphine a day (ten is the standard dose for a terminal cancer patient).
PK data demonstrated an approximately proportional increase in concentration with increasing dose and a terminal half-life of 20 hours.
■ AZD9773 pharmacokinetic data demonstrated an approximately proportional increase in concentration with increasing dose and a terminal half-life of 20 hours.
Ipilimumab PK was linear and time-invariant, with dose-proportional exposures over the available dose range, yielding a terminal half-life of approximately 15 days.
For example, the annual doses produced in a terminal line would be calculated as 5544 selection candidates × 75% productive × 60% used × 25 doses per week × 85% viable semen × 52 weeks.
Following single doses, the plasma exposures exhibited biphasic disposition with a terminal T1/2 of ~10-12 ~10-12
Pharmacokinetic studies indicated a terminal elimination half-life of 2 4 weeks supporting 3-weekly fixed dosing (Ng et al, 2006).
